Esperion Therapeutics
ESPR
#8241
Rank
NZ$0.30 B
Marketcap
$1.55
Share price
9.12%
Change (1 day)
-51.92%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): NZ$15.21 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.33 Billion. , an increase over its 2023 earnings that were of -NZ$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 NZ$12.52 M-104.99%
2023 -NZ$0.26 Billion-15.03%
2022 -NZ$0.3 Billion-20.61%
2021 -NZ$0.38 Billion84.28%
2020 -NZ$0.21 Billion35.75%
2019 -NZ$0.15 Billion-55.71%
2018 -NZ$0.34 Billion19.57%
2017 -NZ$0.29 Billion125.39%
2016 -NZ$0.13 Billion51.43%
2015 -NZ$82.18 Million36.45%
2014 -NZ$60.23 Million43.55%
2013 -NZ$41.96 Million145.26%
2012 -NZ$17.11 Million
2002 -NZ$48.78 Million-7.81%
2001 -NZ$52.91 Million15.03%
2000 -NZ$45.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.85 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.90 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.53 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.97 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$47.97 Million-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.34 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA